Arkolith/Insider Trading/NKGN/Form 4

Song Paul Y.

Chief Executive Officer, DirectorNKGen Biotech, Inc. (NKGN) · full profile →Form 4 · filed Nov 28, 2023
Net Buying
Open-Market Buys
$701
Open-Market Sells
$0
Net Open-Market Flow
$701
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 27, 2023Buy(P)140$2.85$400171K
Nov 27, 2023Buy(P)103$2.91$300171K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-056768) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML